Lcd. Wijnaendts et al., HISTOPATHOLOGICAL CLASSIFICATION OF CHILDHOOD RHABDOMYOSARCOMAS - RELATIONSHIP WITH CLINICAL-PARAMETERS AND PROGNOSIS, Human pathology, 25(9), 1994, pp. 900-907
To define a useful and prognostically relevant classification system f
or rhabdomyosarcomas (RMSs), tissue sections of 113 well-documented, p
rotocol-treated cases were retrieved from the files of the Emma Kinder
ziekenhuis Amsterdam, the Netherlands, and reclassified by a panel of
pediatric pathologists. The following subtypes were recognized: embryo
nal RMS (n = 66), alveolar RMS (including the solid variant) (n = 16),
botryoid RMS (n = 11), embryonal sarcoma (n = 6), and spindle cell RM
S (n = 5). Nine cases were classified as RMS not otherwise specified (
NOS). The above-mentioned histopathological subtypes correlated signif
icantly with survival (P = .005) in patients with nonparameningeal tum
ors. Indeed, the best prognosis was observed in patients with spindle
cell RMS, embryonal sarcoma, and botryoid RMS (10-year survival rates
of 80% to 86%). Patients with embryonal RMS had an intermediate progno
sis (10-year survival rate of 55%) and patients with alveolar RMS fare
d poorly (10-year survival rate of 9%). Survival rate was poor in pati
ents with a localized parameningeal tumor, irrespective of histopathol
ogical subtype (10-year survival rate of 33%). Furthermore, this study
confirmed the known impact on prognosis of localization (P =.008) and
tumor node metastasis (TNM) stage (P = .0005). Classification of RMS
subtypes proved to be fairly well reproducible (kappa ranging from 0.4
7 to 0.85 and percentage of concordance ranging from 50% to 85%). The
best agreement was noted in botryoid RMS and the worst in embryonal sa
rcoma. However, improvement of agreement was noted for the latter subt
ype during the consecutive classification sessions. In summary, this s
tudy shows the strong prognostic value of histopathological subtypes a
nd parameningeal tumor localization. HUM PATHOL 25:900-907. Copyright
(C) 1994 by W.B. Saunders Company